The FDA has granted ViiV Healthcare priority review for cabotegravir, a new, injectable form of PrEP administered every two months.
London sexual health clinic 56 Dean Street noted the impact of combining treatment and prevention methods in reducing new HIV infections
As the delta variant runs rampant, gay doctors detail how LGBTQ people can help to slow the spread.
Moderna has launched clinical trials for an HIV vaccine, which is based on the same mRNA technology as its COVID-19 vaccine
Department of Labor guidance instructs insurers to remove all costs associated with PrEP, including lab tests and clinic visits
Oxford University has launched a limited trial of the vaccine, which has been developed to target a "broad range" of HIV variants
The CDC has found that more than 4 in 10 transgender women in major U.S. cities have tested positive for HIV.
Merck said results of a study into islatravir suggested it could be used to prevent and treat HIV
Viiv Healthcare's Cabenuva replaces a traditional daily pill regimen with two injections every month
Bimonthly injections were previously found to be more effective than daily pills at preventing HIV transmission
The VA allegedly didn’t tell a Navy veteran he was HIV-positive for 20 years.
Wenger’s Grocery Outlet told customers to respect those not wearing masks by calling LGBTQ people sinful and diseased
Tony Green ignored the "scamdemic" until he hosted a gathering that infected his loved ones with COVID-19
Only 39% of gay and bisexual men said they had told partners about COVID-like symptoms or a positive diagnosis
LGBTQ people of color are more likely to have reduced work hours, ask for delays for bills and rent, and be unemployed during the pandemic